Delisting risk
PPBT · NASDAQ · Biotechnology

Purple Biotech (ADR) (PPBT)

Develops CAPTN-3 tri-specific cancer antibodies and other oncology drug candidates.

$1.81
Pre-market−0.17 (−8.35%)
At close$1.98(+18.98%)

Breakdown13F · 13D/G · Form 4

Institutions14 holders · as of Mar 31, 202654.79%75.7K ADS
Otherremainder45.21%62.4K ADS

138.1K ADS as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

The share count has not been confirmed by a second filing; stakes use it as it stands.

Some positions are filed in underlying shares, not receipts; the ratio is unknown, so no percentage.

A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Susquehanna International Group, LLPInstitution
38.67%53,403 ADS13Fas of Mar 31, 2026
Smartharvest Portfolios, LLCInstitution
13.13%18,127 ADS13Fas of Mar 31, 2026
BNP Paribas Arbitrage, SNCInstitution
1.42%1,957 ADS13Fas of Mar 31, 2026
Rhumbline AdvisersInstitution
0.51%710 ADS13Fas of Mar 31, 2026
Simplex Trading, LLCInstitution
0.43%597 ADS13Fas of Mar 31, 2026
Morgan StanleyInstitution
0.42%578 ADS13Fas of Mar 31, 2026
Gamma Investing LLCInstitution
0.08%108 ADS13Fas of Mar 31, 2026
UBS Group AGInstitution
0.07%99 ADS13Fas of Mar 31, 2026
Sbi Securities Co., Ltd.Institution
0.02%31 ADS13Fas of Mar 31, 2026
Group One Trading, L.P.Institution
0.01%20 ADS13Fas of Mar 31, 2026
Advisory Services Network, LLCInstitution
0.01%9 ADS13Fas of Mar 31, 2026
Northwestern Mutual Wealth Management CoInstitution
0.01%8 ADS13Fas of Mar 31, 2026
Jones Financial Companies LLLPInstitution
0.00%5 ADS13Fas of Mar 31, 2026
Danske Bank A/SInstitution
0.00%4 ADS13Fas of Mar 31, 2026
Ido Agmon1Insiderdirector
Form 4filed Apr 6, 2026
CVI Investments, Inc.Strategic
9.90% of class, as filed13Gfiled Mar 20, 2020
Gil Efron1Insiderofficer: Chief Executive Officer
Form 4filed Mar 31, 2026
Empery Asset Management, LPInstitution
4.99% of class, as filed13G/Afiled Jan 15, 2020
Robert E. Gagnon2Insiderdirector
0.00%0Form 4filed Mar 18, 2026
Heights Capital Management, Inc.Strategic
0.80% of class, as filed13G/Afiled Feb 16, 2021
Shai S. Lankry1Insiderdirector
Form 4filed Mar 27, 2026
Lincoln Alternative Strategies LLCStrategic
9.90% of class, as filed13Gfiled Sep 9, 2025
Mitchell P. KopinInsider
9.99% of class, as filed13Gfiled May 13, 2026
Pontifax Management II L.P.Institution
0.50% of class, as filed13G/Afiled Feb 5, 2021
Simcha Rock1Insiderdirector
Form 4filed Apr 17, 2026
  1. This position is filed in underlying shares, not receipts; the ratio is unknown, so no percentage.
  2. Robert E. Gagnon reports a block also reported by another filer; it is counted once, under that filer.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

14 holders · 75.7K shares

HolderShares% outstandingChg q/qFiled
Susquehanna International Group, LLP53.4K38.67%May 15, 2026
Smartharvest Portfolios, LLC18.1K13.13%Apr 21, 2026
BNP Paribas Arbitrage, SNC2.0K1.42%May 12, 2026
Rhumbline Advisers7100.51%May 12, 2026
Simplex Trading, LLC5970.43%May 14, 2026
Morgan Stanley5780.42%May 15, 2026
Gamma Investing LLC1080.08%Apr 6, 2026
UBS Group AG990.07%May 5, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Mitchell P. Kopin9.99%13GMay 13, 2026
Lincoln Alternative Strategies LLC9.90%13GSep 9, 2025
Susquehanna Securities, LLC5.20%13GFeb 13, 2026

Insider tradesForm 4

Latest trades

Nothing filed in the last 12 months.

CongressHouse and Senate disclosures

Not reported.